Some buy side analysts are also providing their Analysis on Genetic Technologies Limited, where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 1 Analysts reported that the Price Target for Genetic Technologies Limited might touch $12.5 high while the Average Price Target and Low price Target is $12.5 and $12.5 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Genetic Technologies Limited got Upgrade on 13-Feb-14 where investment firm Ladenburg Thalmann Upgrade the stock from Neutral to Buy.
Genetic Technologies Limited closed its last trading session at $1.31 with the gain of 63.73%. The Market Capitalization of the company stands at 24.85 Million. The Company has 52-week high of $3.87 and 52-week low of $1.2. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 58.57% where SMA50 and SMA200 are 38.26% and 5.1% respectively. The Company Touched its 52-Week High on Dec 2, 2015 and 52-Week Low on Oct 28, 2016.
The Relative Volume of the company is 466.19 and Average Volume (3 months) is 56.01 million. Genetic Technologies Limited P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -61.9%. The Return on Equity (ROE) value stands at -71.8%. While it’s Return on Investment (ROI) value is -71%.
While looking at the Stock’s Performance, Genetic Technologies Limited currently shows a Weekly Performance of 55.07%, where Monthly Performance is 57.72%, Quarterly performance is 8.63%, 6 Months performance is -9.32% and yearly performance percentage is -37.79%. Year to Date performance value (YTD perf) value is -20.15%. The Stock currently has a Weekly Volatility of 20.86% and Monthly Volatility of 11.84%.